From Name

From Email

To Name

To Email

Message

Follow up data for IAP antagonist shows improved OS for patients with high-risk head and neck cancer

from Cancer Network

Follow up data for IAP antagonist shows improved OS for patients with high-risk head and neck cancer Cancer Network Data from a three-year follow up found that an inhibitor of apoptosis proteins antagonist with chemo-radiation therapy significantly improved overall survival for patients with high-risk locally advanced squamous cell carcinoma of the head and neck compared to the control group, a Debiopharm press release announced. READ MORE

more